ANDA HOLDINGS

In today’s generic drug industry, intense cost pressure is a constant. We understand that every dollar counts, so we
provide an ANDA Holding service to help you manage costly annual Generic Drug User Fee Amendments (GDUFA)
Program Fees.

ANDA Holding Process

In the ANDA Holding process, ownership of an ANDA, or group of ANDAs, is transferred to Pharmobedient. Upon
transfer, Pharmobedient acts as a safe deposit box for your file. We safely store the ANDA until the time you want it
transferred back to you. Your information remains completely confidential, and we utilize our regulatory expertise to
maintain the file. We have an established procedure for handling ownership transfers that is simple and easy. For more
information, contact us at  info@pharmobedient.com.
If you are considering discontinuing or withdrawing an ANDA, please keep in mind that discontinued ANDAs continue to
be counted in FDA’s Program Fee calculation. The only way to remove an ANDA from being counted in your Program
Fee is to withdraw the ANDA, a process which must be initiated by April 1 of the prior fiscal year, or to transfer
ownership.
If you are considering withdrawing an ANDA, please contact us info@pharmobedient.com for a
proposal.

GDUFA Fee Information

GDUFA Program Fees are paid annually, on October 1, by all companies with an approved ANDA. The fee is categorized
into three tiers, Small, Medium, and Large, and the amount due is based upon the number of approved ANDAs held by a
company and its affiliates.

FY 2022 and FY 2023 User Fee Rates

User Fee Type

 

FY 2022

FY 2023

ANDA

 

$ 225,712

$ 240,582

DMF

 

$ 74,952

$ 78,293

Program

Large Size

$ 1,536,856

$ 1,620,556

 

Medium Size

$ 614,742

$ 648,222

 

Small Size

$ 153,686

$ 162,056

Facility

Domestic API

$ 42,557

$ 37,544

 

Foreign API

$ 57,557

$ 52,544

 

Domestic FDF

$ 195,012

$ 213,134

 

Foreign FDF

$ 210,012

$ 228,134

 

Domestic CMO

$ 65,004

$ 51,152

 

Foreign CMO

$ 80,004

$ 66,152

Backlog

 

$ 17,434

$ 17,434

*Source: FDA website, https://www.fda.gov/industry/fda-user-fee-programs/generic-drug-user-fee- amendments

 

Contact

10 + 4 =

COMPANY

Strategy for complex issues in drug development and life-cycle management.

CONTACT

642 NE 3rd Avenue
Fort Lauderdale FL 33304

TEL. #

(954) 348-9455